Faiz Bhora, MD, FACS, discusses how data from the CheckMate 816, KEYNOTE-091, and AEGEAN trial have transformed perioperative therapy in resectable NSCLC.
Faiz Bhora, MD, FACS
Advertisement
Faiz Bhora, MD, FACS, serves as Professor of Surgery at the Hackensack Meridian School of Medicine and holds the prestigious roles of Regional Chair of Surgery and Chief of Thoracic Surgery for Hackensack Meridian Health’s Central Region.
Articles by Faiz Bhora, MD, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
3
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5